News Sanofi

Equities

SAN

FR0000120578

Market Closed - Euronext Paris Other stock markets 11:36:46 2024-04-23 am EDT			5-day change	1st Jan Change
88.85 ^EUR	+0.77%		+1.60%	-1.01%

Apr. 23	Sector Update: Health Care Stocks Rise Late Afternoon	MT
Apr. 23	Sector Update: Health Care	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Rise Late Afternoon	Apr. 23	MT
Sector Update: Health Care	Apr. 23	MT
Sanofi Asks Banks to Pitch for Roles on Separation of Consumer Health Care Business	Apr. 23	MT
Sanofi Is Said To Ask Banks To Pitch For $20 Billion OTC Spinoff - Bloomberg News	Apr. 23	RE
CAC40: up sharply, back over 8100 pts	Apr. 23	CF
CAC40: back to 8100, E-Stoxx to 5000, Nasdaq +1.5	Apr. 23	CF
CAC40: closes in on 8,100, well supported by W-Street	Apr. 23	CF
CAC40: up slightly after encouraging PMI figures	Apr. 23	CF
Sanofi: positive phase III data in IPT	Apr. 23	CF
Sanofi Reports Positive Results from Phase 3 Trial of Rilzabrutinib for Immune Thrombocytopenia	Apr. 23	MT
Sanofi Says Blood-Disorder Drug Meets Key Target in Late-Stage Trial	Apr. 23	DJ
Sanofi Reaches $100 Million Settlement for US Lawsuits Over Zantac Cancer Claims	Apr. 23	MT
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia	Apr. 23	GL
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia	Apr. 23	AQ
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading	Apr. 22	MT
European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations	Apr. 22	MT
Top Midday Stories: Verizon Shares Down, Truist Shares Up Post Earnings; CNH Industrial Names New Chief Executive; Tesla Dissolves Newly Created Marketing Team	Apr. 22	MT
Sanofi to Pay More Than $100 Million to Settle 4,000 Suits Alleging Zantac Causes Cancer	Apr. 22	MT
Sanofi Reportedly Agrees to Settle Zantac Cancer Lawsuits for More Than $100 Million	Apr. 22	MT
SANOFI : Gets a Buy rating from UBS	Apr. 22	ZD

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Looking beyond the quarterly miss, Sanofi remains an attractive bet

February 01, 2024 at 11:26 am EST

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm EST